French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...
China-based Junshi Biosciences has established a joint venture with Immorna to develop and commercialize new drugs for t...
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...
South Korean firm Celltrion Group has announced new results from an in vivo efficacy study showing that regdan...
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...
Japan headquartered Sosei Group Corporation, the world leader in GPCR-focused structure-based drug design...
VICO Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating t...
Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment f...
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bact...
Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...
UK-based Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has signed an agreement with the m...
